PregnancyNCT02689739
Validation of Ultrasound in Predicting a Low Lying Placenta Throughout Pregnancy
An observational study of Pregnancy and Obese, run by The University of Texas Medical Branch, Galveston at 1 site in United States.
Trial summary
This is a prospective observational study comparing venous Doppler flow in the lower extremities of pregnant women. Pregnant women with a BMI >/= 30 will be compared to those with a BMI < 30. Read more about this study
- Who is it for?
- Ages 18 to 50 years, women onlyHealthy volunteers can take part
- What is being tested?
- venous duplex ultrasound
- Type of treatment
- Surgery or procedure
- How many people
- 0 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Jul 2015to 30 Jun 2016
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- Women only
- Healthy volunteers accepted
- Adult
Study population: This is a prospective study comparing venous Doppler flow in the lower extremities of pregnant women. Pregnant women with a BMI >/= 30 will be compared to those with a BMI < 30 who deliver at UTMB.
Who may be able to join
- Age >/= 18 years of age, planned delivery at John Sealy Hospital (JSH)
Who cannot join
- <18 years of age
- Personal history of VTE, regardless of etiology
- Development of VTE during this pregnancy -History of thrombophilia, bleeding disorder marked varicosities, history of recurrent stillbirth, intrauterine growth restriction
- Any indication for emergency delivery
- Known major fetal abnormality or genetic syndrome
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Texas Medical Branch
Galveston, Texas, 77555
About this study
Official title: Lower-extremity Blood fl ow and Velocity in Obese vs Nonobese Pregnant Women
This is a prospective observational study comparing venous Doppler flow in the lower extremities of pregnant women. Pregnant women with a BMI >/= 30 will be compared to those with a BMI < 30.
Read the detailed description
Study Outcome Measurement and Ascertainment:
Data will be collected from data in EPIC and UTMB electronic medical records. This information will include:
- Maternal demographic data, medical, family, personal, social and surgical history
- Maternal pre-pregnancy weight and height
- Maternal weight at time of delivery
- Maternal weight on post-operative day 1
- Gestational age at delivery, infant gender, birth weight, placental weight, delivery method, and complications through 6 weeks postpartum.
Venous hemodynamics will be obtained using venous duplex ultrasound. 1. Peak, mean, and minimum flow velocities and diameter will be obtained. Calculations of venous velocity amplitude, cross-sectional area, and shear stress will be made from the data collected.
Study Procedures:
This is a prospective study using duplex ultrasound techniques to characterize venous flow in obese and non-obese pregnant patients. Women will be consented to participate and then separated into a study group of obese women (BMI >/= 30) and a control group of non-obese women (BMI <30). These women will be admitted to Labor and Delivery for management of pregnancy. The Doppler US will then be performed by trained staff on the lower extremity. The flow data described above will be measured and compared between the two groups. Additional measurements will be collected during hospitalization.
Criteria for Inclusion of Subjects:
-Age >/= 18 years of age, planned delivery at John Sealy Hospital (JSH)
Criteria for Exclusion of Subjects:
- <18 years of age
- Personal history of VTE, regardless of etiology
- Development of VTE during this pregnancy -History of thrombophilia, bleeding disorder marked varicosities, history of recurrent stillbirth, intrauterine growth restriction
- Any indication for emergency delivery
- Known major fetal abnormality or genetic syndrome
Sources of Research Material:
The sources of data to be used include maternal medical records from EPIC as well as the data obtained from the venous ultrasound.
Recruitment Methods and Consenting Process:
The subjects will be pregnant women who plan a delivery at JSH. Subjects will be consented by study personnel. Patients will not receive any monetary gain. They will understand that this is voluntary and will not affect their care.
Potential Risks:
The Doppler velocimetry is the modality that has been used in pregnancy to assess for the presence of DVT, thus, the safety has been assessed and widely studied. This poses minimum risk to the mother or to the fetus.
Subject Safety and Data Monitoring:
This study does not place subjects at risk of their safety. This modality is well studied to be safe in pregnancy.
Data monitoring will be performed only by study personnel. Data may be assessed prior to the study being completed to assess to see if statistical analysis reveals any difference and if the study can be stopped early.
Procedures to Maintain Confidentiality:
Data will only be viewed by study personnel. The data will then be de-identified and a study number will be assigned to each patient. The patient's identity will then be secured on an UTMB encrypted laptop device and a hard copy stored in the locked file cabinet in the locked office of the investigator.
Potential Benefits:
There are no benefits to subjects participating in the study. By gathering the information of duplex velocimetry in both the obese and non-obese population we can determine if there is a change in the velocimetry in this at risk population.
- Being tested
- venous duplex ultrasound
- Medical subject headings
- Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
venous duplex ultrasoundProcedure or surgery
Venous duplex ultrasound
| Study group | Role | What they receive |
|---|---|---|
| Obese Pregnant cohort | Women will be consented to participate and then separated into a study group of obese women (BMI >/= 30). Receives: Procedure: venous duplex ultrasound | |
| Non-obese Pregnant cohort | This will be the control group of non-obese women (BMI <30). Receives: Procedure: venous duplex ultrasound |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in venous duplex velocity
To assess if the increased risk of venous thromboembolism is observed in obese versus non-obese pregnant patients is due to compromised flow in the lower extremities.
Measured: On admission for delivery of the infant and postpartum day 1 and 2
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Feb 2016 (estimated)
- Study start1 Jul 2015
- Primary completion30 Jun 2016
- Study completion30 Jun 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PregnancyStudies of the same condition, open and under way.
- More trials run by The University of Texas Medical Branch, GalvestonThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Gayle Olson, MD, Study director, UTMB
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02689739
- Sponsor's protocol ID
- 15-0143
- Status last verified
- Mar 2019
- First submitted
- 13 Feb 2016
- Last updated
- 26 Oct 2020
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No: We do not plan to share data.
Study at a glance
From the registry record, last updated by the sponsor on 26 Oct 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Lower-extremity Blood fl ow and Velocity in Obese vs Nonobese Pregnant Women
- ClinicalTrials.gov ID
- NCT02689739
- Acronym / sponsor ID
- 15-0143
- Study type
- Observational
- Recruitment status
- Withdrawn
- Enrolment
- 0 participants (actual)
- Lead sponsor
- The University of Texas Medical Branch, GalvestonUniversity, hospital or other
- Study start
- 1 Jul 2015 (actual)
- Primary completion
- 30 Jun 2016 (actual)
- Study completion
- 30 Jun 2016 (actual)
- First posted
- 24 Feb 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a prospective observational study comparing venous Doppler flow in the lower extremities of pregnant women. Pregnant women with a BMI >/= 30 will be compared to those with a BMI < 30.
Detailed description
Study Outcome Measurement and Ascertainment:
Data will be collected from data in EPIC and UTMB electronic medical records. This information will include:
- Maternal demographic data, medical, family, personal, social and surgical history
- Maternal pre-pregnancy weight and height
- Maternal weight at time of delivery
- Maternal weight on post-operative day 1
- Gestational age at delivery, infant gender, birth weight, placental weight, delivery method, and complications through 6 weeks postpartum.
Venous hemodynamics will be obtained using venous duplex ultrasound. 1. Peak, mean, and minimum flow velocities and diameter will be obtained. Calculations of venous velocity amplitude, cross-sectional area, and shear stress will be made from the data collected.
Study Procedures:
This is a prospective study using duplex ultrasound techniques to characterize venous flow in obese and non-obese pregnant patients. Women will be consented to participate and then separated into a study group of obese women (BMI >/= 30) and a control group of non-obese women (BMI <30). These women will be admitted to Labor and Delivery for management of pregnancy. The Doppler US will then be performed by trained staff on the lower extremity. The flow data described above will be measured and compared between the two groups. Additional measurements will be collected during hospitalization.
Criteria for Inclusion of Subjects:
-Age >/= 18 years of age, planned delivery at John Sealy Hospital (JSH)
Criteria for Exclusion of Subjects:
- <18 years of age
- Personal history of VTE, regardless of etiology
- Development of VTE during this pregnancy -History of thrombophilia, bleeding disorder marked varicosities, history of recurrent stillbirth, intrauterine growth restriction
- Any indication for emergency delivery
- Known major fetal abnormality or genetic syndrome
Sources of Research Material:
The sources of data to be used include maternal medical records from EPIC as well as the data obtained from the venous ultrasound.
Recruitment Methods and Consenting Process:
The subjects will be pregnant women who plan a delivery at JSH. Subjects will be consented by study personnel. Patients will not receive any monetary gain. They will understand that this is voluntary and will not affect their care.
Potential Risks:
The Doppler velocimetry is the modality that has been used in pregnancy to assess for the presence of DVT, thus, the safety has been assessed and widely studied. This poses minimum risk to the mother or to the fetus.
Subject Safety and Data Monitoring:
This study does not place subjects at risk of their safety. This modality is well studied to be safe in pregnancy.
Data monitoring will be performed only by study personnel. Data may be assessed prior to the study being completed to assess to see if statistical analysis reveals any difference and if the study can be stopped early.
Procedures to Maintain Confidentiality:
Data will only be viewed by study personnel. The data will then be de-identified and a study number will be assigned to each patient. The patient's identity will then be secured on an UTMB encrypted laptop device and a hard copy stored in the locked file cabinet in the locked office of the investigator.
Potential Benefits:
There are no benefits to subjects participating in the study. By gathering the information of duplex velocimetry in both the obese and non-obese population we can determine if there is a change in the velocimetry in this at risk population.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Obese Pregnant cohort | – | Procedure: venous duplex ultrasoundWomen will be consented to participate and then separated into a study group of obese women (BMI >/= 30). |
| Non-obese Pregnant cohort | – | Procedure: venous duplex ultrasoundThis will be the control group of non-obese women (BMI <30). |
Who may qualify
- Ages
- 18 to 50 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- This is a prospective study comparing venous Doppler flow in the lower extremities of pregnant women. Pregnant women with a BMI >/= 30 will be compared to those with a BMI < 30 who deliver at UTMB.
Key inclusion criteria (1 listed)
- Age >/= 18 years of age, planned delivery at John Sealy Hospital (JSH)
Key exclusion criteria (5 listed)
- <18 years of age
- Personal history of VTE, regardless of etiology
- Development of VTE during this pregnancy -History of thrombophilia, bleeding disorder marked varicosities, history of recurrent stillbirth, intrauterine growth restriction
- Any indication for emergency delivery
- Known major fetal abnormality or genetic syndrome
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| venous duplex ultrasoundVenous duplex ultrasound | Procedure or surgery | Non-obese Pregnant cohort, Obese Pregnant cohort |
Primary outcome
Change in venous duplex velocity
Time frame: On admission for delivery of the infant and postpartum day 1 and 2
To assess if the increased risk of venous thromboembolism is observed in obese versus non-obese pregnant patients is due to compromised flow in the lower extremities.
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Oct 2020.
- Individual participant dataSharing planned: No. We do not plan to share data.
Related trials for Pregnancy
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingObservational study
Population Pharmacokinetics of Temocillin in Acute Enterobacterial Pyelonephritis in Children
Pyelonephritis
Active, not recruitingPhase 3
A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)
Carcinoma, Renal Cell
Recruiting
Safety and Performance of UCon Patch Electrode
Urinary Incontinence, Urinary Incontinence, Urge
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gayle Olson, MD study director
UTMB
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pregnancy and Obese, run by The University of Texas Medical Branch, Galveston at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 26 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in venous duplex velocity (time frame: On admission for delivery of the infant and postpartum day 1 and 2). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2020.